Pegylated liposomal doxorubicin hydrochloride injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pegylated liposomal doxorubicin hydrochloride injection, covering 2011-05-17 to 2011-05-17. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Clinical Study of Pegylated Liposomal Doxorubicin Hydrochloride Injection as 2nd-line or Later Therapy in Patients With Mullerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having Prior Platinum-Based Chemotherapy [Phase 2]